AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

DUBAI, UAE - Media OutReach Newswire - 24 September 2024 - AstraZeneca, a global leader in the pharmaceutical and biotechnology sector, has been recognized with ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.

Johnson & Johnson's stock has seen modest gains in recent months. Read why I downgrade JNJ stock from buy to hold.

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

The greatest disparity in BC-specific survival was observed in women with HR+ HER2− tumors, with Black women having a 50% ...